Continuing in our series of Sigma analysis of the leading diagnostic platforms, we turn our attention to the Abbott Alinity, and assess what goals can be achieved by this chemistry instrument.
Taking some recent cobas 8000 data, we assess what goals can be achieved by one of the leading chemistry platforms.
There may be 50 ways to leave your lover, but how many ways can you break the "Westgard Rules"? Can you guess? You may be surprised by the possibilities.
Standarization or Standarisation? Harmonization or Harmonisation? We seem to be headed toward a schism in performance specifications, rather than a consensus. Here's a current comparison of Global Performance Specifications for Chemistry Assays.
In February 2019, the Centers for Medicaid and Medicare issued proposed changes to the CLIA regulations. This is potentially the largest shake-up in US regulations in decades.
Innovative Diagnostics has become the first (and fastest) private laboratory in Singapore to achieve the Verification of Performance in May 2016. Further, it verified an additional branch (Camden) of the laboratory in September 2016. A total of more than 80 analytes, including chemistry, immunoassay, hormones and tumor markers on multiple instruments.
CLIA has posted a proposed set of new quality requirements for proficiency testing. Here's what was listed in the Federal Register for public comment.